Polaris Partners

Polaris Partners is a venture capital firm founded in 1996 and headquartered in Boston, Massachusetts. With additional offices in San Francisco and New York, the firm specializes in investing across all stages of technology and healthcare companies, including life sciences and biotechnology. Polaris has established a strong track record over its more than 20 years in the industry, focusing on partnering with repeat entrepreneurs and innovators who are enhancing quality of life and work. The firm's investments are directed primarily within the United States and Europe, supporting companies from their founding stages to profitable growth.

William Allard

Venture Partner

Jonathan Ang

Entrepreneur Partner

Mark Augenstern

Associate

David Barrett

Managing Partner

David Barrett

Partner

Marissa Bertorelli

Principal

Mary Blair

CFO

Alexandra Cantley

Partner

Darren Carroll

Partner

Brian Chee

Managing Partner

Isaac Ciechanover

Partner

Alan Crane

Partner and Entrepreneur

Jon Flint

Founding Partner

Jonathan Flint

Founding Partner

Harold Friedman

CFO

John Gannon

CFO and Partner

Nil Gural

Senior Associate

Brendan Hannigan

Entrepreneur Partner

Rahul Kakkar

Entrepreneur Partner

Pat Kinsel

Partner

Scott Martin

Senior Associate

Eileen McGuire

Partner

Ellie McGuire

Partner

Terry McGuire

Founding Partner

Sabrina Chiasson

Principal

Pat Mulach

Senior Associate

Kim Png

Principal

Noel Ruane

Venture Partner

Jim Weinstein

Entrepreneur Partner

Past deals in Boston, MA

Dewpoint Therapeutics

Series C in 2022
Dewpoint Therapeutics, Inc. is a Boston-based biotechnology company focused on the research and development of biomolecular condensates to create innovative treatments for a range of diseases, including cancer, neurodegenerative disorders, immunology, cardiovascular issues, women's health, and virology. Founded in 2018, the company utilizes a proprietary, AI-powered drug discovery platform that employs machine learning and advanced image analysis to visualize and manipulate biomolecular condensates. This technology aids in identifying novel drug candidates and has applications across various therapeutic areas. Dewpoint Therapeutics collaborates with leading academic and pharmaceutical partners to enhance its research and development efforts, aiming to deliver impactful healthcare solutions.

Ankyra

Series B in 2021
Provider of cancer therapy services intended to improve both the safety and efficacy of cytokine immunotherapies for cancer patients. The company's services offer systemic dosing of these immune stimulants that have historically been limited by broad immune activation and toxicity, develops cancer therapies based on tumor-localized immune potentiating agents that boost anti-tumor immune responses, enabling patients to find an instant treatment for cancer without any surgery.

Cardurion

Venture Round in 2021
Cardurion Pharmaceuticals, LLC is a biotechnology company based in Boston, Massachusetts, established in 2017. The company focuses on developing innovative therapeutics for heart failure and other cardiovascular diseases. In a significant partnership with Takeda Pharmaceutical Company, announced in July 2017, Cardurion aims to create next-generation treatments for these conditions, utilizing external innovation to enhance its discovery programs. Additionally, in April 2018, Cardurion entered an exclusive licensing agreement with Astellas for the development and commercialization of CRD-733, a PDE-9 inhibitor. This compound shows promise in improving cardiac function in heart failure patients by potentially restoring protective cellular mechanisms that fail in this condition.

Jnana Therapeutics

Series B in 2021
Jnana Therapeutics Inc. is a Boston-based company founded in 2016 that operates a drug discovery platform centered on solute carrier (SLC) transporters. The company focuses on key disease pathways related to immunometabolism, lysosomal function, and mucosal defense, targeting areas such as immuno-oncology, inflammatory disorders, and neurological diseases. By leveraging its innovative approach, Jnana Therapeutics aims to discover and develop transformative medicines that address significant medical needs and improve patient outcomes.

OM1

Series D in 2021
OM1, Inc. is a digital health company that develops a platform aimed at measuring and forecasting patient outcomes data for healthcare organizations. The platform supports hospitals and health systems in meeting requirements for patient-reported and clinical outcomes, particularly in value-based care programs and bundle payments. By leveraging advanced analytics, the platform provides predictive and prescriptive insights that help mitigate risks and reduce costs while demonstrating outcomes to various stakeholders. OM1's technology synthesizes and enriches clinical data to offer AI-driven insights that enhance clinical, financial, and operational management, thereby establishing a new standard for health outcomes information. Founded in 2014 and based in Boston, Massachusetts, OM1 was previously known as Better Outcomes Corporation.

Akili Interactive

Series D in 2021
Akili Interactive Labs, Inc. is a digital medicine company based in Boston, Massachusetts, that develops innovative platform technology to enhance cognitive abilities through video game-like experiences. Incorporated in 2011, the company focuses on creating clinically validated cognitive therapeutics, assessments, and diagnostics that can be prescribed and monitored by physicians remotely. Akili's cognitive engine supports multiple clinical game versions designed for patient engagement and remote data capture. Its proprietary adaptive mechanics allow the software to personalize to each patient's ability level automatically, without requiring clinician input. This approach aims to provide a cost-effective alternative to traditional medical treatments, making advanced cognitive therapies accessible to patients regardless of their location.

PathAI

Series C in 2021
PathAI, Inc. develops artificial intelligence-based technology solutions for pathology laboratories. It develops a technology that assists pathologists in making rapid and accurate diagnoses for patients. The company also builds solutions to help identify patients that benefit from novel therapies, to make scalable personalized medicine a reality. PathAI, Inc. was founded in 2016 and is based in Boston, Massachusetts with an additional office in Austin, Texas.

Cohere Health

Series B in 2021
Cohere Health, Inc. is a software-as-a-service company based in Boston, Massachusetts, that focuses on enhancing the healthcare experience for patients, providers, and health plans. Incorporated in 2019, the company aims to improve the quality of care while reducing overall costs and increasing transparency throughout the patient care journey. Cohere Health specializes in intelligent prior authorization services, which are tailored to meet the specific needs of different health plans. By leveraging artificial intelligence, machine learning, and real-time analytics, the company automates the prior authorization process and facilitates collaboration between physicians and health plans. This approach not only streamlines the utilization management service but also promotes quality care across the entire patient journey.

Tausight

Series A in 2021
Tausight, Inc. develops a software for reducing healthcare cyber incidents of patient data theft. It serves chief information officer of health care sector. Tausight was founded in 2018 and is based in Sudbury, Massachusetts with additional office in San Francisco, California.

FOLX

Series A in 2021
Folx Health is a digital health services platform that builds a medical service marketplace tailored towards the queer community. It combines access to a specialized network of queer and trans clinicians with a tailored focus on clinical offerings that are typically marginalized in traditional health settings. The startup focuses on providing patients gender-affirming hormone therapy, sexual health, and family creation services. Other services include erectile dysfunction treatment, PrEP, and STI testing. The company was founded by Agneta Breitenstein in 2019 in Boston, Massachusets.

Dewpoint Therapeutics

Series B in 2020
Dewpoint Therapeutics, Inc. is a Boston-based biotechnology company focused on the research and development of biomolecular condensates to create innovative treatments for a range of diseases, including cancer, neurodegenerative disorders, immunology, cardiovascular issues, women's health, and virology. Founded in 2018, the company utilizes a proprietary, AI-powered drug discovery platform that employs machine learning and advanced image analysis to visualize and manipulate biomolecular condensates. This technology aids in identifying novel drug candidates and has applications across various therapeutic areas. Dewpoint Therapeutics collaborates with leading academic and pharmaceutical partners to enhance its research and development efforts, aiming to deliver impactful healthcare solutions.

Ankyra

Seed Round in 2020
Provider of cancer therapy services intended to improve both the safety and efficacy of cytokine immunotherapies for cancer patients. The company's services offer systemic dosing of these immune stimulants that have historically been limited by broad immune activation and toxicity, develops cancer therapies based on tumor-localized immune potentiating agents that boost anti-tumor immune responses, enabling patients to find an instant treatment for cancer without any surgery.

FOLX

Venture Round in 2020
Folx Health is a digital health services platform that builds a medical service marketplace tailored towards the queer community. It combines access to a specialized network of queer and trans clinicians with a tailored focus on clinical offerings that are typically marginalized in traditional health settings. The startup focuses on providing patients gender-affirming hormone therapy, sexual health, and family creation services. Other services include erectile dysfunction treatment, PrEP, and STI testing. The company was founded by Agneta Breitenstein in 2019 in Boston, Massachusets.

Proof

Series C in 2020
Notarize, Inc. operates an online notary platform that allows individuals and businesses to have documents notarized remotely through live video calls with commissioned eNotaries. Founded in May 2015 and headquartered in Boston, Massachusetts, Notarize provides several services, including a general notary service, Notarize for Business for organizations and developers, and Notarize for Mortgage, which streamlines the closing process by connecting lenders, title companies, and borrowers online. The platform is accessible via iOS, Android, and web applications, making it convenient for users. Notarize also offers an electronic will service, enhancing its suite of digital legal solutions. The company focuses on identity verification to ensure secure transactions, thereby helping clients protect their business and maintain compliance with notarization requirements.

Iora Health

Series F in 2020
Iora Health, Inc. is a healthcare provider based in Boston, Massachusetts, specializing in primary care services across the United States. Founded in 2010, the company is committed to overcoming the barriers typically present in the healthcare system by offering personalized care for each patient. Each individual is assigned a dedicated personal physician and health coach, who maintain regular communication through various channels, including email, text, and video, in addition to in-person consultations. Iora Health employs a team-based approach that includes a doctor or nurse practitioner, nurse, behavioral health specialist, and health coach, all supported by a proprietary technology platform for effective population health management. The organization also provides educational programs, such as group visits, to assist patients in achieving their health goals and managing their overall well-being.

OM1

Series C in 2019
OM1, Inc. is a digital health company that develops a platform aimed at measuring and forecasting patient outcomes data for healthcare organizations. The platform supports hospitals and health systems in meeting requirements for patient-reported and clinical outcomes, particularly in value-based care programs and bundle payments. By leveraging advanced analytics, the platform provides predictive and prescriptive insights that help mitigate risks and reduce costs while demonstrating outcomes to various stakeholders. OM1's technology synthesizes and enriches clinical data to offer AI-driven insights that enhance clinical, financial, and operational management, thereby establishing a new standard for health outcomes information. Founded in 2014 and based in Boston, Massachusetts, OM1 was previously known as Better Outcomes Corporation.

Cardurion

Private Equity Round in 2019
Cardurion Pharmaceuticals, LLC is a biotechnology company based in Boston, Massachusetts, established in 2017. The company focuses on developing innovative therapeutics for heart failure and other cardiovascular diseases. In a significant partnership with Takeda Pharmaceutical Company, announced in July 2017, Cardurion aims to create next-generation treatments for these conditions, utilizing external innovation to enhance its discovery programs. Additionally, in April 2018, Cardurion entered an exclusive licensing agreement with Astellas for the development and commercialization of CRD-733, a PDE-9 inhibitor. This compound shows promise in improving cardiac function in heart failure patients by potentially restoring protective cellular mechanisms that fail in this condition.

Proof

Series B in 2019
Notarize, Inc. operates an online notary platform that allows individuals and businesses to have documents notarized remotely through live video calls with commissioned eNotaries. Founded in May 2015 and headquartered in Boston, Massachusetts, Notarize provides several services, including a general notary service, Notarize for Business for organizations and developers, and Notarize for Mortgage, which streamlines the closing process by connecting lenders, title companies, and borrowers online. The platform is accessible via iOS, Android, and web applications, making it convenient for users. Notarize also offers an electronic will service, enhancing its suite of digital legal solutions. The company focuses on identity verification to ensure secure transactions, thereby helping clients protect their business and maintain compliance with notarization requirements.

Dewpoint Therapeutics

Series A in 2019
Dewpoint Therapeutics, Inc. is a Boston-based biotechnology company focused on the research and development of biomolecular condensates to create innovative treatments for a range of diseases, including cancer, neurodegenerative disorders, immunology, cardiovascular issues, women's health, and virology. Founded in 2018, the company utilizes a proprietary, AI-powered drug discovery platform that employs machine learning and advanced image analysis to visualize and manipulate biomolecular condensates. This technology aids in identifying novel drug candidates and has applications across various therapeutic areas. Dewpoint Therapeutics collaborates with leading academic and pharmaceutical partners to enhance its research and development efforts, aiming to deliver impactful healthcare solutions.

Drizly

Series C in 2018
Drizly is an e-commerce alcohol marketplace and the best way to shop beer, wine, and spirits. With the speed and convenience of on-demand delivery and shipping, Drizly partners with retailers in 235 markets to offer consumers of legal drinking age unrivaled selection and a transparent, personalized shopping experience. Backed by world-class institutional investors, Drizly partners with retailers to bring their shelves online, helping them to reach new customers, tap into key market and customer insights, and diversify their business to grow sales.

ClearSky Data

Venture Round in 2018
ClearSky Data operates a global storage network that provides enterprise storage as a fully managed service, simplifying the entire data lifecycle for businesses. Its innovative Smart Tiered Caching technology categorizes data into hot, warm, and cold tiers based on usage, allowing customers to efficiently manage and scale their storage needs through an intuitive dashboard. The service enables seamless data movement across the network for various applications, including data center migration and disaster recovery, while ensuring low-latency access to cloud instances through partnerships with major public cloud providers. ClearSky's model significantly reduces the total cost of ownership compared to traditional physical storage arrays, offering a cost-effective solution for demanding workloads. The company emphasizes high availability, security, and resilience, employing industry-leading technologies to protect customer data from the moment it enters the network, allowing enterprises to focus on their core operations without worrying about data management.

OM1

Series B in 2018
OM1, Inc. is a digital health company that develops a platform aimed at measuring and forecasting patient outcomes data for healthcare organizations. The platform supports hospitals and health systems in meeting requirements for patient-reported and clinical outcomes, particularly in value-based care programs and bundle payments. By leveraging advanced analytics, the platform provides predictive and prescriptive insights that help mitigate risks and reduce costs while demonstrating outcomes to various stakeholders. OM1's technology synthesizes and enriches clinical data to offer AI-driven insights that enhance clinical, financial, and operational management, thereby establishing a new standard for health outcomes information. Founded in 2014 and based in Boston, Massachusetts, OM1 was previously known as Better Outcomes Corporation.

Iora Health

Series E in 2018
Iora Health, Inc. is a healthcare provider based in Boston, Massachusetts, specializing in primary care services across the United States. Founded in 2010, the company is committed to overcoming the barriers typically present in the healthcare system by offering personalized care for each patient. Each individual is assigned a dedicated personal physician and health coach, who maintain regular communication through various channels, including email, text, and video, in addition to in-person consultations. Iora Health employs a team-based approach that includes a doctor or nurse practitioner, nurse, behavioral health specialist, and health coach, all supported by a proprietary technology platform for effective population health management. The organization also provides educational programs, such as group visits, to assist patients in achieving their health goals and managing their overall well-being.

Jnana Therapeutics

Series A in 2017
Jnana Therapeutics Inc. is a Boston-based company founded in 2016 that operates a drug discovery platform centered on solute carrier (SLC) transporters. The company focuses on key disease pathways related to immunometabolism, lysosomal function, and mucosal defense, targeting areas such as immuno-oncology, inflammatory disorders, and neurological diseases. By leveraging its innovative approach, Jnana Therapeutics aims to discover and develop transformative medicines that address significant medical needs and improve patient outcomes.

Drizly

Series B in 2017
Drizly is an e-commerce alcohol marketplace and the best way to shop beer, wine, and spirits. With the speed and convenience of on-demand delivery and shipping, Drizly partners with retailers in 235 markets to offer consumers of legal drinking age unrivaled selection and a transparent, personalized shopping experience. Backed by world-class institutional investors, Drizly partners with retailers to bring their shelves online, helping them to reach new customers, tap into key market and customer insights, and diversify their business to grow sales.

Incredible Foods

Venture Round in 2017
Incredible Foods, Inc. is a Boston-based manufacturer of non-dairy frozen products sold under the perfectlyfree brand. Established in 2012, the company specializes in creating delicious and allergy-friendly food options, including fruit bites, frozen bites, and frozen pints. Its offerings are designed to be "Big 8 Allergy-Friendly," meaning they do not contain the eight most common allergens: dairy, wheat, peanuts, tree nuts, eggs, soy, fish, and shellfish. All products are made with natural, premium, non-GMO ingredients in a dedicated facility that ensures a safe and allergen-free environment. Incredible Foods aims to enhance the lives of its consumers by providing enjoyable and health-conscious food choices. The company operates as a subsidiary of Quantum Designs, LLC and rebranded from Wikifoods, Inc. in July 2016.

Iora Health

Series D in 2016
Iora Health, Inc. is a healthcare provider based in Boston, Massachusetts, specializing in primary care services across the United States. Founded in 2010, the company is committed to overcoming the barriers typically present in the healthcare system by offering personalized care for each patient. Each individual is assigned a dedicated personal physician and health coach, who maintain regular communication through various channels, including email, text, and video, in addition to in-person consultations. Iora Health employs a team-based approach that includes a doctor or nurse practitioner, nurse, behavioral health specialist, and health coach, all supported by a proprietary technology platform for effective population health management. The organization also provides educational programs, such as group visits, to assist patients in achieving their health goals and managing their overall well-being.

Proof

Seed Round in 2016
Notarize, Inc. operates an online notary platform that allows individuals and businesses to have documents notarized remotely through live video calls with commissioned eNotaries. Founded in May 2015 and headquartered in Boston, Massachusetts, Notarize provides several services, including a general notary service, Notarize for Business for organizations and developers, and Notarize for Mortgage, which streamlines the closing process by connecting lenders, title companies, and borrowers online. The platform is accessible via iOS, Android, and web applications, making it convenient for users. Notarize also offers an electronic will service, enhancing its suite of digital legal solutions. The company focuses on identity verification to ensure secure transactions, thereby helping clients protect their business and maintain compliance with notarization requirements.

NDVR

Seed Round in 2016
Developer of an investment advisory platform designed to improve portfolio management services. The company's platform offers portfolio optimization algorithms and technology, enabling investors to get better results and better wealth management information.

ClearSky Data

Series B in 2015
ClearSky Data operates a global storage network that provides enterprise storage as a fully managed service, simplifying the entire data lifecycle for businesses. Its innovative Smart Tiered Caching technology categorizes data into hot, warm, and cold tiers based on usage, allowing customers to efficiently manage and scale their storage needs through an intuitive dashboard. The service enables seamless data movement across the network for various applications, including data center migration and disaster recovery, while ensuring low-latency access to cloud instances through partnerships with major public cloud providers. ClearSky's model significantly reduces the total cost of ownership compared to traditional physical storage arrays, offering a cost-effective solution for demanding workloads. The company emphasizes high availability, security, and resilience, employing industry-leading technologies to protect customer data from the moment it enters the network, allowing enterprises to focus on their core operations without worrying about data management.

Drizly

Series A in 2015
Drizly is an e-commerce alcohol marketplace and the best way to shop beer, wine, and spirits. With the speed and convenience of on-demand delivery and shipping, Drizly partners with retailers in 235 markets to offer consumers of legal drinking age unrivaled selection and a transparent, personalized shopping experience. Backed by world-class institutional investors, Drizly partners with retailers to bring their shelves online, helping them to reach new customers, tap into key market and customer insights, and diversify their business to grow sales.

Iora Health

Series C in 2015
Iora Health, Inc. is a healthcare provider based in Boston, Massachusetts, specializing in primary care services across the United States. Founded in 2010, the company is committed to overcoming the barriers typically present in the healthcare system by offering personalized care for each patient. Each individual is assigned a dedicated personal physician and health coach, who maintain regular communication through various channels, including email, text, and video, in addition to in-person consultations. Iora Health employs a team-based approach that includes a doctor or nurse practitioner, nurse, behavioral health specialist, and health coach, all supported by a proprietary technology platform for effective population health management. The organization also provides educational programs, such as group visits, to assist patients in achieving their health goals and managing their overall well-being.

Logentries

Series A in 2013
Logentries is a software-as-a-service (SaaS) company that specializes in log management and analytics, designed to make machine-generated log data accessible to developers, operations teams, and business analysts. Unlike traditional log management solutions, which often require advanced technical skills and significant setup costs, Logentries offers a user-friendly alternative that allows organizations to manage large volumes of data effectively. The platform enables real-time search capabilities and proactively alerts users about potential system errors and remedies, helping to prevent system crashes. With a global presence, Logentries serves over 20,000 users across more than 100 countries and processes billions of events daily, facilitating the visualization and sharing of critical insights across various business functions.

Iora Health

Series B in 2013
Iora Health, Inc. is a healthcare provider based in Boston, Massachusetts, specializing in primary care services across the United States. Founded in 2010, the company is committed to overcoming the barriers typically present in the healthcare system by offering personalized care for each patient. Each individual is assigned a dedicated personal physician and health coach, who maintain regular communication through various channels, including email, text, and video, in addition to in-person consultations. Iora Health employs a team-based approach that includes a doctor or nurse practitioner, nurse, behavioral health specialist, and health coach, all supported by a proprietary technology platform for effective population health management. The organization also provides educational programs, such as group visits, to assist patients in achieving their health goals and managing their overall well-being.

Spindle

Venture Round in 2012
Spindle, Inc. operates in the payment processing sector, offering services to small and medium-sized businesses through its Catalyst Gateway platform. The company not only provides payment processing solutions but also acts as an intermediary by connecting merchants to other processors, earning ongoing fees based on processing volumes. Additionally, Spindle offers integrated marketing programs under its Catalyst brand, focusing on enhancing business operations and customer engagement. Headquartered in Marco Island, Florida, the company aims to support its clients with comprehensive marketing and commerce solutions.

docTrackr

Seed Round in 2012
docTrackr is a digital document management service designed to give businesses control and visibility over their sensitive documents. The platform allows users to manage permissions, track document usage, and remotely destroy or update documents, even after they have been shared or extracted from the platform. By integrating with popular document management tools like Dropbox and Google Drive, docTrackr enhances existing workflows without replacing them. Its technology empowers organizations to maintain security and compliance by providing real-time insights into document interactions. Founded in the United States and with a presence in Europe, docTrackr has been recognized for its innovation in the tech space, having participated in the prestigious TechStars accelerator program. The company was acquired for $10 million, further solidifying its position in the digital document security market.

Logentries

Seed Round in 2012
Logentries is a software-as-a-service (SaaS) company that specializes in log management and analytics, designed to make machine-generated log data accessible to developers, operations teams, and business analysts. Unlike traditional log management solutions, which often require advanced technical skills and significant setup costs, Logentries offers a user-friendly alternative that allows organizations to manage large volumes of data effectively. The platform enables real-time search capabilities and proactively alerts users about potential system errors and remedies, helping to prevent system crashes. With a global presence, Logentries serves over 20,000 users across more than 100 countries and processes billions of events daily, facilitating the visualization and sharing of critical insights across various business functions.

Fate Therapeutics

Series B in 2011
Fate Therapeutics is using the fundamental biological mechanisms that guide cell fate to develop stem cell therapeutics. The company has brought together the foremost scientists from the nation's research hotbeds (Boston, San Francisco, San Diego, and Seattle) who have demonstrated the potential to create and modulate stem cells to restore health. The backstory is that while others were working towards therapies based on transplanting stem cell-derived cells into patients, Randall Moon (HHMI and the University of Washington) and Alex Rives (Arch Venture Capitol) envisioned a different approach to develop regenerative therapies. The concept, based on data from hematopoietic progenitor cells, was that one could modulate the properties of stem cells in vivo using small molecules or biologics. They presented this idea to Arch Venture Capitol in Seattle, which launched the company, soon to be joined by other investors.

Fate Therapeutics

Series B in 2009
Fate Therapeutics is using the fundamental biological mechanisms that guide cell fate to develop stem cell therapeutics. The company has brought together the foremost scientists from the nation's research hotbeds (Boston, San Francisco, San Diego, and Seattle) who have demonstrated the potential to create and modulate stem cells to restore health. The backstory is that while others were working towards therapies based on transplanting stem cell-derived cells into patients, Randall Moon (HHMI and the University of Washington) and Alex Rives (Arch Venture Capitol) envisioned a different approach to develop regenerative therapies. The concept, based on data from hematopoietic progenitor cells, was that one could modulate the properties of stem cells in vivo using small molecules or biologics. They presented this idea to Arch Venture Capitol in Seattle, which launched the company, soon to be joined by other investors.

Ironwood Pharmaceuticals

Venture Round in 2009
Ironwood Pharmaceuticals, Inc. is a healthcare company headquartered in Boston, Massachusetts, specializing in the development and commercialization of gastrointestinal products. The company markets linaclotide, a medication used to treat irritable bowel syndrome with constipation and chronic idiopathic constipation, under the brand names LINZESS in the United States and CONSTELLA in Canada and the European Union. Additionally, Ironwood is developing MD-7246, an oral, non-opioid pain relief agent for abdominal pain related to gastrointestinal diseases, and IW 3718, a bile acid sequestrant currently in Phase III trials for gastroesophageal reflux disease (GERD). The company has established collaboration agreements with Allergan and AstraZeneca for the commercialization of linaclotide across various regions, including North America and Asia, and a licensing agreement with Astellas Pharma for the Japanese market. Founded in 1998, Ironwood Pharmaceuticals was previously known as Microbia, Inc. and has evolved to focus on addressing significant unmet needs in gastrointestinal and other therapeutic areas.

Experience.com

Venture Round in 2009
Experience.com is a company that focuses on enhancing the workforce experience by helping individuals understand their interests and aptitudes in relation to career opportunities. Founded in 1996, it aims to empower the next generation by providing insights into how to apply their talents effectively. The company operates an experience management platform that enables businesses to influence employee behavior and improve customer experiences. This platform integrates customer feedback mechanisms that generate valuable insights, enhance online reviews, and support marketing automation and local search optimization. By doing so, Experience.com assists clients in improving their online reputation and driving revenue growth.

Hangout Industries

Series B in 2009
Hangout is building the next generation in social gaming by combining the powerful community of social networks with the rich immersion and engaging casual game-play of a 3D virtual world. Play Games, Go Shopping, Throw Parties for Causes in Hangout Teen girls (and later guys) create their own personalized avatars, play casual mini-games, go shopping, throw parties for their friends, or just hangout. Playing games earns money for fashionable looks, new moves on the dance floor, or money to give to charity. At launch, players will be able to begin building their fashion empire as they level up to become a top fashion designer. Soon they can also aspire to become a dance master or the ultimate chef in order to throw the party of a lifetime, all in the name of a real charity of their choice. Hangout is about having fun with friends, meeting new people, and making a difference! Hangout Uniquely Integrates Social Games with a Virtual World Each game te publish seamlessly plugs into the same virtual world, so players keep their avatars, possessions, and status from game to game. The integrated publishing approach results in improved cross-promotion and better player retention and monetization.

Ember

Venture Round in 2009
Ember is a design-oriented company specializing in temperature control technologies that enhance the way individuals consume food and beverages. Founded by inventor Clay Alexander, Ember has developed a range of patented products, including the world’s first temperature control smart mug, which allows users to customize the temperature of their drinks for optimal flavor. The company aims to revolutionize industries such as healthcare and wellness by creating advanced temperature-adjustable dishware and drinkware. By focusing on precise temperature control, Ember seeks to improve user experiences and drive significant changes in how people eat, drink, and live.

Fate Therapeutics

Series A in 2007
Fate Therapeutics is using the fundamental biological mechanisms that guide cell fate to develop stem cell therapeutics. The company has brought together the foremost scientists from the nation's research hotbeds (Boston, San Francisco, San Diego, and Seattle) who have demonstrated the potential to create and modulate stem cells to restore health. The backstory is that while others were working towards therapies based on transplanting stem cell-derived cells into patients, Randall Moon (HHMI and the University of Washington) and Alex Rives (Arch Venture Capitol) envisioned a different approach to develop regenerative therapies. The concept, based on data from hematopoietic progenitor cells, was that one could modulate the properties of stem cells in vivo using small molecules or biologics. They presented this idea to Arch Venture Capitol in Seattle, which launched the company, soon to be joined by other investors.

Solace Pharmaceuticals

Series A in 2007
Solace Pharmaceuticals, a Boston based drug company focused on therapeutics for chronic pain.

Hangout Industries

Series A in 2007
Hangout is building the next generation in social gaming by combining the powerful community of social networks with the rich immersion and engaging casual game-play of a 3D virtual world. Play Games, Go Shopping, Throw Parties for Causes in Hangout Teen girls (and later guys) create their own personalized avatars, play casual mini-games, go shopping, throw parties for their friends, or just hangout. Playing games earns money for fashionable looks, new moves on the dance floor, or money to give to charity. At launch, players will be able to begin building their fashion empire as they level up to become a top fashion designer. Soon they can also aspire to become a dance master or the ultimate chef in order to throw the party of a lifetime, all in the name of a real charity of their choice. Hangout is about having fun with friends, meeting new people, and making a difference! Hangout Uniquely Integrates Social Games with a Virtual World Each game te publish seamlessly plugs into the same virtual world, so players keep their avatars, possessions, and status from game to game. The integrated publishing approach results in improved cross-promotion and better player retention and monetization.

Ember

Series C in 2006
Ember is a design-oriented company specializing in temperature control technologies that enhance the way individuals consume food and beverages. Founded by inventor Clay Alexander, Ember has developed a range of patented products, including the world’s first temperature control smart mug, which allows users to customize the temperature of their drinks for optimal flavor. The company aims to revolutionize industries such as healthcare and wellness by creating advanced temperature-adjustable dishware and drinkware. By focusing on precise temperature control, Ember seeks to improve user experiences and drive significant changes in how people eat, drink, and live.

GoTo

Series B in 2005
LogMeIn, Inc. offers a comprehensive suite of cloud-based solutions focused on communication, collaboration, identity management, and customer engagement. The company provides products such as GoToMeeting, a platform for online meetings; GoToWebinar, designed for webinars; and GoToTraining, for interactive training sessions. Additionally, it offers tools like LogMeIn Pro for remote access, LastPass for password management, and Bold360 for customer engagement. Other notable services include Jive, a cloud-based phone system, and Rescue, which provides remote support and customer care. LogMeIn serves a diverse range of clients, including enterprise customers, small and medium businesses, IT service providers, and consumers. Founded in 2003 and headquartered in Boston, Massachusetts, LogMeIn was taken private in 2020.

Ember

Venture Round in 2004
Ember is a design-oriented company specializing in temperature control technologies that enhance the way individuals consume food and beverages. Founded by inventor Clay Alexander, Ember has developed a range of patented products, including the world’s first temperature control smart mug, which allows users to customize the temperature of their drinks for optimal flavor. The company aims to revolutionize industries such as healthcare and wellness by creating advanced temperature-adjustable dishware and drinkware. By focusing on precise temperature control, Ember seeks to improve user experiences and drive significant changes in how people eat, drink, and live.

Ember

Series B in 2002
Ember is a design-oriented company specializing in temperature control technologies that enhance the way individuals consume food and beverages. Founded by inventor Clay Alexander, Ember has developed a range of patented products, including the world’s first temperature control smart mug, which allows users to customize the temperature of their drinks for optimal flavor. The company aims to revolutionize industries such as healthcare and wellness by creating advanced temperature-adjustable dishware and drinkware. By focusing on precise temperature control, Ember seeks to improve user experiences and drive significant changes in how people eat, drink, and live.

Ember

Seed Round in 2001
Ember is a design-oriented company specializing in temperature control technologies that enhance the way individuals consume food and beverages. Founded by inventor Clay Alexander, Ember has developed a range of patented products, including the world’s first temperature control smart mug, which allows users to customize the temperature of their drinks for optimal flavor. The company aims to revolutionize industries such as healthcare and wellness by creating advanced temperature-adjustable dishware and drinkware. By focusing on precise temperature control, Ember seeks to improve user experiences and drive significant changes in how people eat, drink, and live.

eSupportNow

Venture Round in 2000
Founded in 1998, eSupportNow (www.esupportnow.com) is located in Boston, Massachusetts. The company maintains an infrastructure specifically designed to accommodate the necessary operations, staffing and technology required to provide online customer service and sales support. eSN is a spin-off of The Cross Country Group which, for more than 25 years, has been a recognized leader in outsourced customer service solutions that enable companies to develop, foster and expand their relationships with existing and prospective customers.

Experience.com

Venture Round in 2000
Experience.com is a company that focuses on enhancing the workforce experience by helping individuals understand their interests and aptitudes in relation to career opportunities. Founded in 1996, it aims to empower the next generation by providing insights into how to apply their talents effectively. The company operates an experience management platform that enables businesses to influence employee behavior and improve customer experiences. This platform integrates customer feedback mechanisms that generate valuable insights, enhance online reviews, and support marketing automation and local search optimization. By doing so, Experience.com assists clients in improving their online reputation and driving revenue growth.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.